Clostridium difficile in Children: To Treat or Not to Treat?
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Clostridium difficile infection has been increasing since 2000 in children and in adults. Frequent antibiotics use, co-morbidity, and the development of hypervirulent strains have increased the risk of infection. Despite the high carriage rates of C. difficile, infants rarely develop clinical infection. Discontinuing antibiotics and supportive management usually leads to resolution of disease. Antibiotics use should be stratified depending on the patient’s age and severity of the disease.
Abstract
Clostridium difficile infection has been increasing since 2000 in children and in adults. Frequent antibiotics use, co-morbidity, and the development of hypervirulent strains have increased the risk of infection. Despite the high carriage rates of C. difficile, infants rarely develop clinical infection. Discontinuing antibiotics and supportive management usually leads to resolution of disease. Antibiotics use should be stratified depending on the patient’s age and severity of the disease.
참고문헌 (25)
- Surawicz CM, "Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections", Am J Gastroenterol, 108, pp.478~498 (2013)
- 서검석, "Clostridium difficile Infection: What’s New?", Intestinal research, 11(1), pp.1~13 (2013), 대한장연구학회
- Nylund CM, "Clostridium difficile infection in hospitalized children in the United States", Arch Pediatr Adolesc Med, 165, pp.451~457 (2011)
- Khanna S, "The epidemiology of community-acquired Clostridium difficile infection: a population-based study", Am J Gastroenterol, 107, pp.89~95 (2012)
- Thibault A, "Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak", Infect Control Hosp Epidemiol, 12, pp.345~348 (1991)
- Warny M, "Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe", Lancet, 366, pp.1079~1084 (2005)
- McFarland LV, "Update on the changing epidemiology of Clostridium difficile-associated disease", Nat Clin Pract Gastroenterol Hepatol, 5, pp.40~48 (2008)
- Bauer MP, "Clostridium difficile infection in Europe: a hospital-based survey", Lancet, 377, pp.63~73 (2011)
- Cohen SH, "Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)", Infect Control Hosp Epidemiol, 31, pp.431~455 (2010)
- Toltzis P, "Presence of the epidemic North American Pulsed Field type 1 Clostridium difficile strain in hospitalized children", J Pediatr, 154, pp.607~608 (2009)
- Al-Jumaili IJ, "Incidence and origin of Clostridium difficile in neonates", J Clin Microbiol, 19, pp.77~78 (1984)
- Bryant K, "Clostridium difficile infections in children", Pediatr Infect Dis J, 28, pp.145~146 (2009)
- 장주영, "Monitoring of Clostridium difficile Colonization in Preterm Infants in Neonatal Intensive Care Units", Pediatric Gastroenterology, Hepatology & Nutrition, 15(1), pp.29~37 (2012), 대한소아소화기영양학회
- Eglow R, "Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor", J Clin Invest, 90, pp.822~829 (1992)
- El Feghaly RE, "Viral co-infections are common and are associated with higher bacterial burden in children with clostridium difficile infection", J Pediatr Gastroenterol Nutr, 57, pp.813~816 (2013)
- Deshpande A, "Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis", Clin Gastroenterol Hepatol, 10, pp.225~233 (2012)
- Toltzis P, "High proportion of false-positive Clostridium difficile enzyme immunoassays for toxin A and B in pediatric patients", Infect Control Hosp Epidemiol, 33, pp.175~179 (2012)
- Johnson S, "Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial", Ann Intern Med, 117, pp.297~302 (1992)
- Pant C, "Clostridium difficile infection in children: a comprehensive review", Curr Med Res Opin, 29, pp.967~984 (2013)
- Zar FA, "A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity", Clin Infect Dis, 45, pp.302~307 (2007)
- Jardin CG, "Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy", J Hosp Infect, 85, pp.28~32 (2013)
- Pai S, "Five years experience of Clostridium difficile infection in children at a UK tertiary hospital: proposed criteria for diagnosis and management", PLoS One, 7, pp.e51728~ (2012)
- Schutze GE, "Clostridium difficile infection in infants and children", Pediatrics, 131, pp.196~200 (2013)
- Johnston BC, "Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis", Ann Intern Med, 157, pp.878~888 (2012)
- van Nood E, "Duodenal infusion of donor feces for recurrent Clostridium difficile", N Engl J Med, 368, pp.407~415 (2013)
